CD8A and neoplasm: In addition to these canonical antigen presentation pathways, several recent studies proposed a third pathway of antigen presentation in which DCs acquire the preformed peptide–MHCI complexes from neighboring DCs or tumor cells and activate CD8+ T cells without any further peptide processing (28, 29, 35, 36, 59, 60) (Figure 1C).